Phase 3 Cardiovascular Diseases Clinical Trials

11 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 111 of 11 trials

Recruiting
Phase 3

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1152 locationsNCT07064473
Recruiting
Phase 2Phase 3

PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

ObesityCardiovascular DiseasesHypertension+3 more
University of Alabama at Birmingham160 enrolled1 locationNCT04971720
Recruiting
Phase 3

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

Cardiovascular DiseasesDiabete Type 2
Montreal Heart Institute10,000 enrolled39 locationsNCT05633810
Recruiting
Phase 3

Behavioral Activation Delivered Via Home-based Telehealth to Improve Functioning in Cardiovascular Disease Patients Recently Discharged From Inpatient Care

Cardiovascular DiseasesDepression
VA Office of Research and Development132 enrolled1 locationNCT04877197
Recruiting
Phase 3

Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs

Cardiovascular Diseases
Penn State University65 enrolled1 locationNCT06120400
Recruiting
Phase 3

Aggressive Smoking Cessation Trial (ASAP)

Cardiovascular DiseasesAcute Coronary Syndrome
Sir Mortimer B. Davis - Jewish General Hospital798 enrolled13 locationsNCT05257629
Recruiting
Phase 3

Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery

Cardiovascular DiseasesCardiovascular ComplicationMyocardial Injury+2 more
Cantonal Hospital of St. Gallen880 enrolled1 locationNCT06279000
Recruiting
Phase 3

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

Heart FailureCardiovascular DiseasesType 1 Diabetes+1 more
Steno Diabetes Center Copenhagen2,000 enrolled2 locationsNCT06082063
Recruiting
Phase 3

The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with Cardiovascular Risk

Cardiovascular DiseasesUric Acid
Poznan University of Medical Sciences1,116 enrolled1 locationNCT05943821
Recruiting
Phase 3

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

Heart FailureCardiovascular DiseasesHypertension+5 more
Pulnovo Medical (Wuxi) Co., Ltd.264 enrolled1 locationNCT05824923
Recruiting
Phase 3

Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine

Cardiovascular DiseasesDiabetesAtherosclerosis+1 more
Ottawa Heart Institute Research Corporation115 enrolled2 locationsNCT04181996